FDA reviewing safety of Ziagen and Videx.
D019380:Anti-HIV Agents / Q000009:adverse effects*; D016049:Didanosine / Q000009:adverse effects*; D015224:Dideoxynucleosides / Q000009:adverse effects*; D064420:Drug-Related Side Effects and Adverse Reactions; D006801:Humans; D017202:Myocardial Ischemia / Q000139:chemically induced* / Q000453:epidemiology / Q000209:etiology; D012307:Risk Factors; D014481:United States / Q000453:epidemiology; D014486:United States Food and Drug Administration; D000099227:Abacavir
D019380:Anti-HIV Agents; D016049:Didanosine; D015224:Dideoxynucleosides; D000099227:Abacavir